HYDREA is indicated for the treatment of: • Resistant chronic myeloid leukemia. Locally advanced squamous cell carcinomas of the head and neck (excluding the lip) in combination with chemoradiation. HYDREA is used alone or in conjunction with other antitumor agents or radiation therapy to treat neoplastic diseases.
Hydroxyurea can help people with sickle cell disease live longer . Hydroxyurea is a medicine that doctors have used to treat people with sickle cell disease since the 1980s. The Food and Drug Administration (FDA) approved it for treating adults with sickle cell disease in 1998.
Reviews
There are no reviews yet.